Soleno Therapeutics (SLNO) has had the highest return since January 15, 2023 by a mid-cap US stock in the Nasdaq Composite (IXIC), returning 2,974.2%.
| ASSET | % RETURN |
|---|---|
Soleno Therapeutics (SLNO) | 2,974.25% |
Sezzle Inc Common Stock (SEZL) | 2,333.64% |
Dave (DAVE) | 2,127.77% |
Rigetti Computing (RGTI) | 1,634.38% |
Regencell Bioscience (RGC) | 1,619.08% |
SoundHound AI (SOUN) | 1,054.81% |
American Superconductor (AMSC) | 978.46% |
IREN (IREN) | 894.44% |
Anbio Biotechnology Class A Ordinary Shares (NNNN) | 867.87% |
Terawulf (WULF) | 854.26% |
Quantum Computing (QUBT) | 751.11% |
IES (IESC) | 746.27% |
Sterling Construction (STRL) | 710.33% |
GeneDx (WGS) | 704.43% |
Powell Industries (POWL) | 560.98% |
Applied Digital (APLD) | 534.68% |
Abivax SA American Depositary Shares (ABVX) | 507.24% |
BridgeBio Pharma (BBIO) | 489.89% |
SkyWest (SKYW) | 475.31% |
TMC the metals (TMC) | 464.22% |
ADMA Biologics (ADMA) | 386.82% |
Centessa Pharmaceuticals PLC ADR (CNTA) | 386.52% |
InterDigital (IDCC) | 372.2% |
MoonLake Immunotherapeutics (MLTX) | 360.93% |
Protagonist Therapeutics (PTGX) | 360.34% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
